Table IV.
Prognostic factors according to multivariate analysis.
| Factor | β | SE | Wald | RR (95% CI) | P-value |
|---|---|---|---|---|---|
| Pathological type | 0.476 | 0.166 | 8.241 | 1.069 (1.162–2.227) | 0.004 |
| Surgery | −0.730 | 0.093 | 61.273 | 0.482 (0.401–0.579) | 0.000 |
| Metastasis | 0.673 | 0.089 | 57.536 | 1.960 (1.647–2.332) | 0.000 |
| TNM Stage I | 1.00 | ||||
| TNM Stage II | 0.384 | 0.176 | 4.790 | 1.469 (1.041–2.072) | 0.029 |
| TNM Stage III | 0.269 | 0.102 | 6.800 | 1.310 (1.071–1.603) | 0.009 |
| TNM Stage IV | 0.509 | 0.104 | 24.212 | 1.661 (1.355–2.038) | 0.000 |
| NLR | 0.187 | 0.093 | 4.071 | 1.205 (1.005–1.445) | 0.044 |
| PLR | 0.122 | 0.100 | 1.494 | 1.130 (0.929–1.373) | 0.222 |
TNM, tumor-node-metastasis; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; SE, standard error; RR, relative risk; CI, confidence interval.